Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: A randomized controlled trial

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 5, 2003, Pages 952-957

  Wark, Peter Alexander Blanch ^a,d   Hensley, Michael John ^a   Saltos, Nicholas ^a   Boyle, Michael James ^b   Toneguzzi, Ruth Christine ^a   Simpson, Jodie Louise ^a   McElduff, Patrick ^c   Gibson, Peter Gerard ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Airway inflammation; Allergic bronchopulmonary aspergillosis; Asthma; Induced sputum; Itraconazole

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ITRACONAZOLE; PLACEBO; PREDNISONE;

ANAMNESIS; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHOPULMONARY ASPERGILLOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; EOSINOPHIL; EOSINOPHILIA; HUMAN; IMMUNOMODULATION; LEUKOCYTE COUNT; NAUSEA; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RESPIRATORY TRACT INFLAMMATION; SPIROMETRY; SPUTUM ANALYSIS;

EID: 0038752563     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1388     Document Type: Article

References (25)

1. Varkey B. Allergic bronchopulmonary aspergillosis: clinical perspectives. Immunol Allergy Clin North Am 1998;18:479-501.
2. Katzenstein K, Liebow AA, Friedman PJ. Bronchocentric granulomatosis. Mucoid impaction and hypersensitivity reactions to fungi. Am Rev Respir Dis 1975;3:232-6.
3. Wark PAB, Simpson JL, Saltos N, Slater S, Hensley MJ, Gibson PG. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 2000;16:1095-101.
4. Safirstein BH, D'Souza MF, Simon G, Tai E, Pepys J. Five year followup of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1973;108:450-9.
5. Wark PAB, Gibson PG. Azoles for allergic bronchopulmonary aspergillosis associated with asthma [review]. Cochrane Database Syst Rev 2001;(4):CD001108.
6. Greenberger P. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-92.
7. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis 1987;136:225-44.
8. Twaddell SH, Gibson PG, Carty K, Woolley KL, Henry RL. Assessment of airway inflammation in children with acute asthma using induced sputum. Eur Respir J 1996;9:2104-8.
9. Smith CM, Anderson SD. Inhalation provocation tests using non-isotonic aerosols. J Allergy Clin Immunol 1989;84:781-90.
10. Spanevello A, Confalonieri M, Sulotto F, Romano F, Balzano G, Migliori GB, et al. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 2000;162:1172-4.
11. Sur S, Glitz DG, Kita H, Kujawa SM, Peterson EA, Weiler DA, et al. Localisation of eosinophil derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes. J Leukoc Biol 1998;63:715-22.
12. Wang JL, Patterson R, Roberts M, Ghory AC. The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1979;120:87-92.
13. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome D, Catanzar A, et al. A randomised trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-62.
14. Varis T, Kaukonen K-M, Kivisto KT, Neuvonen PJ. Plasma concentrations and effects of oral methylprednisone are considerably increased by itraconazole. Clin Pharmacol Ther 1998;64:363-8.
15. Lebrun-Vignes B, Chosidow O, Diquet B. Effects of itraconazole on the pharmokinetics on prednisolone and methyprednisolone in healthy subjects. Exp Clin Pharmacol 1996;18(suppl):B207.
16. Skov M, Main KM, Sillesen IB, Muller J, Koch C, Lanng S, Iatrogenic adrenal insufficiency as a side effect of combined treatment of itraconazole and budesonide. Eur Respir J 2002;20:127-33.
17. De Beule K, De Doncker P, Cauwenbergh G, Koster M, Legendre R, Blatchford N, et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses 1988;31:476-85.
18. Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991;100:813-9.
19. Germaud P, Tuchais E, Confrere I, De Lajartre M, Chailleux E, Delobel M. Therapy of allergic bronchopulmonary aspergillosis with itraconazole [abstract]. Am Rev Respir Dis 1992;145:A736.
20. Mannes GPM, van der Heide S, van Aalderen WMC, Gerritsen J. Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis. Lancet 1993;341:492.
21. Pacheco A, Martin JA, Cuevas M. Serological response to itracanazole in allergic bronchopulmonary aspergillosis. Chest 1993;103:980-1.
22. LeBeau B, Pelloux H, Pinel C, Michallet M, Gout JP, Pison C, et al. Itraconazole in the treatment of aspergillosis: a study of 16 cases. Mycoses 1994;37:171-9.
23. Matsuzaki Y, Jimi T, Tao Y, Takada S Miyazaki N. Allergic bronchopulmonary aspergillosis successfully treat with itraconazole. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:352-6.
24. Nikaido Y, Nagata N, Yamamoto T, Yoshii C, Ohmori H, Kido M. A case of allergic bronchopulmonary aspergillosis successfully treated with itraconazole. Respir Med 1998;92:118-24.
25. Neopmuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Chest 1999;115:364-70.